BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Genmab A/S 

Toldbodgade 33

Copenhagen    K-1253  Denmark
Phone: 45-7020-2728 Fax: 45-7020-2729


SEARCH JOBS




 Key Statistics


Email:
Ownership: Public

Web Site: Genmab A/S
Employees:
Symbol: GEN.CO
 



Industry
Biotechnology


Collaborations

Bionomics Limited  Anti-angiogenesis therapeutic antibody development





 Company News
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Wins FDA Approval For Arzerra As First-Line Treatment For Chronic Lymphocytic Leukaemia (CLL) 4/17/2014 4:09:08 PM    More...
Passing Of Genmab A/S (GEN.CO)’ Annual General Meeting 4/10/2014 8:03:03 AM    More...
Constitution Of The Board Of Directors In Genmab A/S (GEN.CO) And Grant Of Warrants To Employees 4/10/2014 7:59:38 AM    More...
Passing Of Genmab A/S (GEN.CO)’ Annual General Meeting 4/9/2014 8:59:12 AM    More...
Genmab A/S (GEN.CO)’s Total Number Of Voting Rights And Total Share Capital 4/1/2014 11:08:45 AM    More...
Genmab A/S (GEN.CO) Reaches $22 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 3/27/2014 7:25:31 AM    More...
Genmab A/S (GEN.CO) Summons Annual General Meeting 3/18/2014 9:16:17 AM    More...
Genmab A/S (GEN.CO) Release: Report Pursuant To Section 28a Of The Danish Securities Trading Act 3/13/2014 9:40:25 AM    More...
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise 3/13/2014 9:38:54 AM    More...
Genmab A/S (GEN.CO) Announces Phase 3 Study Of Daratumumab In Relapsed Or Refractory Multiple Myeloma 3/5/2014 9:34:56 AM    More...
12345678910...